Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Pharmacol Ther. 2019 May 8;200:190–209. doi: 10.1016/j.pharmthera.2019.05.003

Figure 4.

Figure 4.

In vitro cumulative release profiles of (a) FITC-lysozyme and (b) BDNF release from silica supraparticles. Insert in (a) shows the in vitro FITC-lysozyme release profile starting from day 6. Adapted with permission (Ma et al. 2018).